CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device
In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle.
Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.
Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.
Activity